• Glaxo to take 16 percent of Aspen in $418 mln deal

    GlaxoSmithKline will take a 16 percent stake in Africa's biggest generic drug maker, Aspen Pharmacare, to expand its emerging market footprint in a deal worth 3.47 billion rand ($418 million).